Xeplo AZ 250 Tablet contains Azithromycin 250mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It functions by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of susceptible bacteria. Xeplo AZ 250 is indicated for the treatment of respiratory tract infections such as community-acquired pneumonia, acute bacterial sinusitis, and pharyngitis/tonsillitis caused by susceptible organisms. It is also used in the management of skin and soft tissue infections, uncomplicated genital infections including urethritis and cervicitis, and certain gastrointestinal infections like traveler's diarrhea caused by specific pathogens. The tablet is administered orally, with dosing regimens tailored to the type and severity of infection, typically involving a once-daily dose due to its long half-life, which enhances patient compliance. Caution is advised in patients with known hypersensitivity to macrolides or any component of the formulation. Use in patients with hepatic impairment requires careful monitoring. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Xeplo AZ 250 should be used under medical supervision, and it is essential to complete the prescribed course to prevent antibiotic resistance. It is contraindicated in patients with a history of QT prolongation or cardiac arrhythmias.